Enhanced binding and inertness to dehalogenation of α-melanotropic peptides labeled using N-succinimidyl 3-iodobenzoate

Bioconjugate Chemistry

Volumn 7, Issue 2, 1996, Pages 233-239

  Garg, Pradeep K ^a,b   Alston, Kevin L ^a   Welsh, Philip C ^a   Zalutsky, Michael R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CELL CULTURE; DERMATOLOGY; MAMMALS; ONCOLOGY; TISSUE;

CELL LINES; DEIODINATION; IN-VITRO; IODOGEN METHOD; LABELING METHODS; MELANOMA CELLS; POTENTIAL UTILITY; RAPID DEGRADATION; VITRO AND IN VIVO; VITRO BINDING;

PEPTIDES;

1,3,4,6 TETRACHLORO 3 ALPHA,6 ALPHA DIPHENYLGLYCOLURIL; 1,3,4,6-TETRACHLORO-3 ALPHA,6 ALPHA-DIPHENYLGLYCOLURIL; ALPHA INTERMEDIN; DRUG DERIVATIVE; IODOBENZOIC ACID DERIVATIVE; MSH, 4 NLE 7 PHE ALPHA; MSH, 4-NLE-7-PHE-ALPHA-; N SUCCINIMIDYL 3 IODOBENZOATE; N-SUCCINIMIDYL 3-IODOBENZOATE; RADIOACTIVE IODINE; UREA;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BINDING COMPETITION; CELL CULTURE; EXPERIMENTAL MELANOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; METABOLISM; MOLECULAR GENETICS; MOUSE; STOMACH; THYROID GLAND;

ALPHA-MSH; AMINO ACID SEQUENCE; ANIMALS; BINDING, COMPETITIVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; IODINE RADIOISOTOPES; IODOBENZOATES; ISOTOPE LABELING; MELANOMA, EXPERIMENTAL; MICE; MOLECULAR SEQUENCE DATA; STOMACH; THYROID GLAND; TUMOR CELLS, CULTURED; UREA;

EID: 0030091928     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc960001+     Document Type: Article

References (15)

1. 99mTc-labeled hydrazino nicotinamide derivatized chemotactic peptides for imaging focal sites of bacterial infection. J. Nucl. Med. 34, 1964-1974.
2. Babich, J. W., Graham, W., Barrow, S. A., Dragotakes, S. C., Tompkins, R. G., Rubin, R. H., and Fischman, A. J. (1993b) Technetium-99m-labeled chemotactic peptides: comparison with indium-111-labeled white blood cells for localizing acute bacterial infections in rabbits. J. Nucl. Med. 34, 2176-2181.
3. Badger, C. C., Wilbur, D. S., Hadley, S. W., Fritzberg, A. R., and Bernstein, I. D. (1990) Biodistribution of p-iodobenzoyl (PIP) labeled antibodies in a murine lymphoma model. Nucl. Med. Biol. 17, 381-387.
4. 111In]-DTPA-labeled analogues of α-melanocyte-stimulating hormone for melanoma targeting: receptor binding in vitro and in vivo. Int. J. Cancer 58, 749-755.
5. Bakker, W. H., Krenning, E. P., Breeman, W. A., Koper, J. W., Kooij, P. P., Reubi, J.-C. Klijn, J. G., Visser, T. J., Docter, R., and Lamberts, S. W. (1990) Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity, and in vivo application in animals. J. Nucl. Med 31, 1501-1509.
6. Bakker, W. H., Krenning, E. P., Breeman, W. A. Kooij, P. P. M., Reubi, J.-C., Koper, J. W., de Jong, M., Lameris, J. S., Visser, T. J., and Lamberts, S. W. (1991) In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man. J. Nucl. Med. 32, 1184-1189.
7. Bard, D. R., Knight, C. G., and Page-Thomas, D. P. (1990) A chelating derivative of α-melanocyte stimulating hormone as a potential imaging agent for malignant melanoma. Br. J. Cancer 62, 919-922.
8. Chhajlani, V., and Wikberg, J. E. S. (1992) Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309, 417-420.
9. Deschodt-Lanckman, M., Vanneste, Y., Loir, B., Michel, A., Labert, A., Ghanem, G., and Lejeune, F. (1990) Degradation of α-melanocyte stimulating hormone (α-MSH) by Calla endopeptidase 24.11 expressed by human melanoma cells in culture. Int. J. Cancer 46, 1124-1130.
10. Eberle, A. N. (1988) The Melanotropins: Chemistry, Physiology and Mechanisms of Action, pp 1-409. Karger, Basel.
11. 2)-α-melanotropin, and of related peptides. Helv. Chim. Acta 62, 2460-2483.
12. Zalutsky, M. R., and Narula, A. S. (1987) A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine. Appl. Radiat. Isol. 38, 1051-1050.
13. Zalutsky, M. R., and Narula, A. S. (1988) Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-tri-n-butylstaany benzoate intermediate. Cancer Res. 48, 1446-1450.
14. Zalutsky, M. R., Noska, M. A., Colapinto, E. V. Garg, P. K., and Bigner, D. D. (1989a) Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl-3-tri-n-butylstannyl benzoate. Cancer Res. 49, 5543-5549.
15. Zalutsky, M. R. Garg, P. K., Friedman, H. S., and Bigner, D. D. (1989b) Labeling monoclonal antibodies and F'ab fragments with the alpha particle emitting nuclide astatine-211: Preservation of immunoreactivity and in vivo localizing capacity. Proc. Natl. Acad. Sci. U.S.A. 86, 7149-7153.